140 related articles for article (PubMed ID: 16630890)
1. The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability.
Babon JJ; McManus EJ; Yao S; DeSouza DP; Mielke LA; Sprigg NS; Willson TA; Hilton DJ; Nicola NA; Baca M; Nicholson SE; Norton RS
Mol Cell; 2006 Apr; 22(2):205-16. PubMed ID: 16630890
[TBL] [Abstract][Full Text] [Related]
2. Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain.
Babon JJ; Yao S; DeSouza DP; Harrison CF; Fabri LJ; Liepinsh E; Scrofani SD; Baca M; Norton RS
FEBS J; 2005 Dec; 272(23):6120-30. PubMed ID: 16302975
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3.
Bergamin E; Wu J; Hubbard SR
Structure; 2006 Aug; 14(8):1285-92. PubMed ID: 16905102
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
5. Purification of SOCS (Suppressor of Cytokine Signaling) SH2 Domains for Structural and Functional Studies.
Liau NP; Laktyushin A; Babon JJ
Methods Mol Biol; 2017; 1555():173-182. PubMed ID: 28092033
[TBL] [Abstract][Full Text] [Related]
6. Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity.
Babon JJ; Kershaw NJ; Murphy JM; Varghese LN; Laktyushin A; Young SN; Lucet IS; Norton RS; Nicola NA
Immunity; 2012 Feb; 36(2):239-50. PubMed ID: 22342841
[TBL] [Abstract][Full Text] [Related]
7. SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition.
Kershaw NJ; Murphy JM; Liau NP; Varghese LN; Laktyushin A; Whitlock EL; Lucet IS; Nicola NA; Babon JJ
Nat Struct Mol Biol; 2013 Apr; 20(4):469-76. PubMed ID: 23454976
[TBL] [Abstract][Full Text] [Related]
8. The C-terminus of CIS defines its interaction pattern.
Lavens D; Ulrichts P; Catteeuw D; Gevaert K; Vandekerckhove J; Peelman F; Eyckerman S; Tavernier J
Biochem J; 2007 Jan; 401(1):257-67. PubMed ID: 16961462
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2.
Fairlie WD; De Souza D; Nicola NA; Baca M
Biochem J; 2003 Jun; 372(Pt 2):495-502. PubMed ID: 12593670
[TBL] [Abstract][Full Text] [Related]
11. The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase.
Babon JJ; Sabo JK; Soetopo A; Yao S; Bailey MF; Zhang JG; Nicola NA; Norton RS
J Mol Biol; 2008 Sep; 381(4):928-40. PubMed ID: 18590740
[TBL] [Abstract][Full Text] [Related]
12. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
Kristensen SM; Siegal G; Sankar A; Driscoll PC
J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the PX domain, a target of the SH3 domain.
Hiroaki H; Ago T; Ito T; Sumimoto H; Kohda D
Nat Struct Biol; 2001 Jun; 8(6):526-30. PubMed ID: 11373621
[TBL] [Abstract][Full Text] [Related]
14. Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands.
Linossi EM; Li K; Veggiani G; Tan C; Dehkhoda F; Hockings C; Calleja DJ; Keating N; Feltham R; Brooks AJ; Li SS; Sidhu SS; Babon JJ; Kershaw NJ; Nicholson SE
Nat Commun; 2021 Dec; 12(1):7032. PubMed ID: 34857742
[TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling 3 inhibits LPS-induced IL-6 expression in osteoblasts by suppressing CCAAT/enhancer-binding protein {beta} activity.
Yan C; Cao J; Wu M; Zhang W; Jiang T; Yoshimura A; Gao H
J Biol Chem; 2010 Nov; 285(48):37227-39. PubMed ID: 20876575
[TBL] [Abstract][Full Text] [Related]
16. The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo.
Boyle K; Egan P; Rakar S; Willson TA; Wicks IP; Metcalf D; Hilton DJ; Nicola NA; Alexander WS; Roberts AW; Robb L
Blood; 2007 Sep; 110(5):1466-74. PubMed ID: 17510322
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.
Ivancic M; Daly RJ; Lyons BA
J Biomol NMR; 2003 Nov; 27(3):205-19. PubMed ID: 12975581
[TBL] [Abstract][Full Text] [Related]
18. The SOCS box-adapting proteins for ubiquitination and proteasomal degradation.
Linossi EM; Nicholson SE
IUBMB Life; 2012 Apr; 64(4):316-23. PubMed ID: 22362562
[TBL] [Abstract][Full Text] [Related]
19. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
Lubman OY; Waksman G
J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
[TBL] [Abstract][Full Text] [Related]
20. Complex assembly mechanism and an RNA-binding mode of the human p14-SF3b155 spliceosomal protein complex identified by NMR solution structure and functional analyses.
Kuwasako K; Dohmae N; Inoue M; Shirouzu M; Taguchi S; Güntert P; Séraphin B; Muto Y; Yokoyama S
Proteins; 2008 Jun; 71(4):1617-36. PubMed ID: 18076038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
